| Title |
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy
|
|---|---|
| Published in |
Clinical Pharmacology & Therapeutics, January 2018
|
| DOI | 10.1002/cpt.1007 |
| Pubmed ID | |
| Authors |
Matthew P. Goetz, Katrin Sangkuhl, Henk‐Jan Guchelaar, Matthias Schwab, Michael Province, Michelle Whirl‐Carrillo, W. Fraser Symmans, Howard L. McLeod, Mark J. Ratain, Hitoshi Zembutsu, Andrea Gaedigk, Ron H. van Schaik, James N. Ingle, Kelly E. Caudle, Teri E. Klein |
X Demographics
The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 27% |
| Spain | 5 | 23% |
| Monaco | 2 | 9% |
| Japan | 2 | 9% |
| Unknown | 7 | 32% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 14 | 64% |
| Practitioners (doctors, other healthcare professionals) | 5 | 23% |
| Science communicators (journalists, bloggers, editors) | 2 | 9% |
| Scientists | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 283 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 283 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 52 | 18% |
| Student > Master | 32 | 11% |
| Researcher | 27 | 10% |
| Student > Ph. D. Student | 20 | 7% |
| Student > Doctoral Student | 14 | 5% |
| Other | 43 | 15% |
| Unknown | 95 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 63 | 22% |
| Biochemistry, Genetics and Molecular Biology | 51 | 18% |
| Medicine and Dentistry | 32 | 11% |
| Agricultural and Biological Sciences | 17 | 6% |
| Unspecified | 4 | 1% |
| Other | 12 | 4% |
| Unknown | 104 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 44. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 June 2018.
All research outputs
#953,679
of 26,017,215 outputs
Outputs from Clinical Pharmacology & Therapeutics
#114
of 4,619 outputs
Outputs of similar age
#22,146
of 454,511 outputs
Outputs of similar age from Clinical Pharmacology & Therapeutics
#4
of 63 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,619 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.0. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,511 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.